Developer docs
API playgroundTry for free, no card

Search company profiles

NIBRT

Full company profile

uuid002hst1

Namestring
NIBRT
Legal namestring
National Institute of Bioprocessing Research and Training
Websiteurl
nibrt.ie
Company typeenum
Private
Founded yearint
2011
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBlackrock, Ireland
HQ citystring
Blackrock
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biopharmaceutical training, GMP manufacturing training, bioprocessing education, ATMP workforce development, pharmaceutical research services
Industry2 codes
1Industry-Specific Technical & Certification Prep (e.g., Construction, Manufacturing, Energy)
CodeEDAGANANPrimaryYes
2Data, Analytics & AI Training (BI, Data Engineering, ML/GenAI)
CodeBPAEANAHPrimaryNo
NAICS code4 codes
  • Technical and Trade Schools61151
  • Technical and Trade Schools6115
  • Business Schools and Computer and Management Training6114
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Educational Services8200
  • Services-Commercial Physical & Biological Research8731
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Training Services Revenue
TypeProfessional Services
Description

NIBRT generates revenue through delivery of customized industry training programs, open enrollment short courses, and online Academy (NOA) licenses to biopharmaceutical companies and individuals. Course fees vary by program type and duration, with group discounts available for organizational licenses.

nibrt.ie
2Academic Programme Fees
TypeSubscription Recurring
Description

Revenue from Masters programmes and certificate courses delivered in partnership with Irish universities (ATU Sligo, DCU, UCD). Programs include Springboard+ co-funded courses where government/EU funding covers 90-100% of costs for eligible participants.

nibrt.ie
3Government and IDA Ireland Funding
TypeLicensing Royalties
Description

Initial facility funding of €57 million from Government of Ireland through IDA Ireland, with additional €21 million for ATMP extension. Ongoing government support for research activities and workforce development initiatives.

nibrt.ie
4Global Partner Licensing
TypeLicensing Royalties
Description

The Global Partners Programme operates on a license model where partner organizations license NIBRT's expertise to provide biopharma training in their regions. Partners include CASTL, BioHub Maryland, K-NIBRT, Institut Pasteur de Dakar, Heartland BioWorks, and others.

nibrt.ie
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details6 tiers
1Springboard+ Unemployed Participants - Free
ModelSubscriptionBilling cadenceAnnual
Notes

All Springboard+ courses are free for unemployed participants receiving an eligible social welfare payment.

nibrt.ie
2Springboard+ Level 6 Programs - Free for All
ModelSubscriptionBilling cadenceAnnual
Notes

All Level 6 programs are free regardless of employment status.

nibrt.ie
3Springboard+ Level 7-9 Employed Participants - 10% Co-payment
ModelSubscriptionBilling cadenceAnnual
Notes

Employed participants pay 10% of course cost with 90% funded by Springboard+.

nibrt.ie
4NIBRT Global Qualifications (NGQ) Module Fee
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

€500 per NGQ module, in addition to the practical course fee. An 80% HCI Fee Subsidy is available for eligible Irish applicants (first 100 applicants, until end of June 2025).

nibrt.ie
5Short Course Early Bird Discount
ModelUnit PricingBilling cadencePay-as-you-go
Notes

10% early bird discount for booking 3 or more places across any 2026 short courses in a single booking before 21 August 2026.

nibrt.ie
6NIBRT Online Academy (NOA) Group Licenses
ModelSubscriptionBilling cadenceAnnual
Notes

Group license discounts available for organizations training multiple employees. Contact for pricing details.

nibrt.ie
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

NIBRT provides training and research services for the biopharmaceutical manufacturing industry through a GMP-simulated facility in Dublin, Ireland. Its core offering is a comprehensive training ecosystem including customised corporate training, open-enrolment short courses, the NIBRT Online Academy (NOA) on-demand e-learning platform, NIBRT Global Qualifications (NGQs) micro-credentials, academic Masters and Certificate programmes, and a Digital Academy curriculum covering AI, data analytics, and Industry 4.0. The institute also conducts industry-aligned research across analytical science, cell and genetic engineering, informatics, and bioprocess engineering, and licenses its curriculum internationally through the Global Partners Programme.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Workforce readiness challenges reduced from up to 18 months to shorter timeframes through intensive practical training in GMP-simulated environments
+4 more records
Product overview1 text field

NIBRT is a global centre of excellence for biopharmaceutical manufacturing training and research, headquartered in Dublin, Ireland. The core offering is a comprehensive training ecosystem built around a purpose-built, GMP-simulated bioprocessing facility (~8,000 m²) that replicates a modern industrial biopharma plant. This facility supports the primary product — NIBRT Training and Education — which distributes across multiple delivery channels: Customised Industry Training for individual client organisations, Short Open Enrolment Courses on scheduled dates, the NIBRT Online Academy (NOA) on-demand e-learning platform with 55+ modules, Academic Programmes delivered in partnership with ATU Sligo/DCU/UCD, Springboard+ government-funded programmes, and NIBRT Global Qualifications (NGQs) — internationally recognised micro-credentials worth 5 ECTS each. NIBRT's offering is extended by the NIBRT Digital Academy (a structured data/AI/industry 4.0 curriculum developed with Dataworks, GenSpark, and Sartorius), specialised Vaccine Training programmes, and the Global Partners Programme licensing NIBRT's curriculum internationally. Research is delivered through the NIBRT Research division (with Principal Investigators across analytical science, cell/gene engineering, informatics, and bioprocess engineering) and the CONCEPT core facility for early-stage biotherapy development, which hosts the Beacon Optofluidics Platform for single-cell analysis. Major recent expansions include the €21M Advanced Therapies Extension (ATMP facility with seven research labs and two training suites) and the WHO-designated Regional Training Centre for Biomanufacturing in Europe.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership25 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-15
Description

CASTL is Canada's biomanufacturing training partner and Canada's exclusive provider of NIBRT programmes. The strengthened partnership was recognized in the Joint Statement by Canadian Prime Minister Mark Carney and Irish Taoiseach Micheál Martin. Through a new MOU, the organizations will expand joint programming, share expertise through NIBRT's global network of affiliated training centres, and align world-class biomanufacturing training initiatives.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-11
Description

TCD partners with NIBRT through joint Principal Investigator appointments (Prof. Sakis Mantalaris, Prof. Nicki Panoskaltsis) and leadership of Rinn Advanced Therapies centre. Prof. Owen Smith from TCD co-leads the centre focusing on personalized advanced cellular immune therapeutics.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-11
Description

Prof. Damien Thompson at University of Limerick leads Rinn Pharma and Biopharma centre with NIBRT Principal Investigators as co-applicants. The centre focuses on patient-centred medicines and sustainability in drug development.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-06-11
Description

Prof. Abhay Pandit at University of Galway leads Rinn Medical Devices centre with NIBRT Associate Prof. Radka Fahey as a partner.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-11
Description

UCC partners with NIBRT through Prof. Elena Matsa's joint appointment as Principal Investigator focusing on iPSC Cell Therapy Research and Bioprocess Development.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-11
Description

Research Ireland (formerly Science Foundation Ireland) funds the Rinn Research Centres programme with €460 million investment. NIBRT plays central role in three major centres: Rinn Advanced Therapies (€51M), Rinn Pharma and Biopharma (€60M+), and Rinn Medical Devices (€64.5M).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-14
Description

BioHub Maryland partnered with NIBRT to develop specialized biotech workforce training programs supporting Maryland's growing biotech industry. The initiative focuses on advanced training for cell and gene therapies, emphasizing customized education, soft skills development, and regional workforce growth.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-13
Description

Cytiva and NIBRT maintain an ongoing collaboration including the Cytiva Single Use Suite at NIBRT facility and receipt of Cytiva MDPFS PUPSIT System. Cytiva provides advanced bioprocessing equipment for training purposes.

9K-NIBRT (Korean NIBRT)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Korean NIBRT operates as a Global Partner, licensed to deliver NIBRT training programmes in Korea. Partnership supported by Republic of Korea e-Asia, Knowledge Partnership Fund and ADB to combat COVID-19 in Asia and the Pacific.

nibrt.ie
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Institut Pasteur de Dakar is a Global Partner providing NIBRT training capabilities in Senegal as part of WHO's Regional Training Centre network for Africa.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Heartland BioWorks operates as a Global Partner providing NIBRT training programmes in the US Heartland region to support regional biopharma workforce development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

San Jacinto College operates as a Global Partner licensed to deliver NIBRT programmes and training curriculum in their region.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biologics Innovation Facility operates as a Global Partner providing NIBRT-aligned biopharma training and education in their region.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

University of Technology Sydney is a Global Partner exploring biopharma training collaboration in the Australian region.

Strategic tierCoreTypeTechnology or Integration
Description

Sartorius partners with NIBRT for data analytics training courses including Design of Experiments (DoE) using MODDE software and Multivariate Data Analysis (MVDA) using SIMCA software. Dr Chris McCready, Head of Product Innovation at Sartorius Data Analytics, speaks at NIBRT technical events.

Strategic tierCoreTypeTechnology or Integration
Description

Dataworks partners with NIBRT for digitalization training courses including Excel & Power Query Foundations, Power Platform for Biopharma, and Practical Power BI for Biopharma.

Strategic tierCoreTypeTechnology or Integration
Description

GenSpark partners with NIBRT to deliver AI for Biopharma Manufacturing course using the LearnSpark AI learning platform, providing hands-on instructor-led training in NIBRT's GMP-simulated facilities.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

ATU Sligo is NIBRT's primary university partner delivering multiple Masters programmes (MSc in ATMP, MSc in BioIndustry 4.0, MSc in Biopharmaceutical Processing, etc.) and Certificate courses. Recognized with Partnership Alliance of the Year Award 2025.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

DCU partners with NIBRT to deliver the MSc in Bioprocess Engineering programme with practical sessions at NIBRT's state-of-the-art facility.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

UCD is NIBRT's host institution and key academic partner. NIBRT facility is located on UCD campus. UCD partners include joint appointments for Principal Investigators and delivery of MEngSc Biopharmaceutical Engineering programme.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ThermoFisher Scientific collaborates with NIBRT on research initiatives. Sponsors the NIBRT Research Conference 2026.

Strategic tierCoreTypeTechnology or Integration
Description

DataHow partners with NIBRT for technical evenings and training on digital and AI solutions in pharma manufacturing. Dr Alessandro Butté, CEO of DataHow, speaks at NIBRT events on deploying AI in biopharma processes.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Boston Consulting Group collaborated with NIBRT on the Biopharma 4.0 project, recognized with Pharma Industry Awards Project of the Year 2020.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

WHO designated NIBRT as Regional Training Centre for Biomanufacturing for Europe, one of seven global establishments under WHO's Biomanufacturing Workforce Training Initiative. Initiative aims to address critical workforce shortages and enable sustainable local vaccine and biotherapeutic production capabilities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

adMare BioInnovations supports CASTL (NIBRT's Canadian Global Partner) through its adMare Academy, shaping the next generation of life sciences professionals.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Biologics Innovation Facility (BIF)
TypeDirect peer
Description

NIBRT Global Partner delivering NIBRT-aligned biopharma training and education in Australia, operating as one of the eight Global Partners licensing NIBRT's curriculum.

TypeEmerging player
Description

Canada's life sciences industry developer supporting CASTL's NIBRT-aligned training through adMare Academy; comparable mission of building biopharma workforce capability but with broader industry development scope.

TypeDirect peer
Description

Canada's exclusive provider of NIBRT programmes and biomanufacturing training partner; the June 2026 MOU strengthened joint programming, making it a near-clone of NIBRT's model operating in North America.

TypeDirect peer
Description

US-based biomanufacturing training centre at NC State offering hands-on cGMP pilot-scale training comparable to NIBRT's Dublin facility, serving a similar biopharma workforce training mission.

TypeDirect peer
Description

NIBRT Global Partner developing specialised biotech workforce training programmes in Maryland with a focus on cell and gene therapies — directly comparable biomanufacturing training mission in the US.

6BETC (Biomanufacturing Education and Training Center) at Worcester Polytechnic Institute
TypeDirect peer
Description

WPI's BETC delivers industry-aligned biomanufacturing workforce training with pilot-scale facilities, overlapping directly with NIBRT's training-and-research integration model.

TypeDirect peer
Description

Senegal-based WHO Regional Training Centre for Biomanufacturing for Africa, delivering NIBRT-aligned training as part of WHO's seven-centre global network for biomanufacturing workforce development.

TypeDirect peer
Description

NIBRT Global Partner delivering licensed NIBRT programmes and training curriculum to biomanufacturing workforce in the Texas Gulf Coast region.

9K-NIBRT (Korean NIBRT)
TypeDirect peer
Description

Korea's licensed NIBRT Global Partner delivering NIBRT-aligned biopharma training programmes in Korea, supported by Republic of Korea e-Asia Knowledge Partnership Fund and ADB.

TypeDirect peer
Description

US Heartland region NIBRT Global Partner providing NIBRT-licensed biopharma training programmes to support regional workforce development.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NIBRT firmographics

Firmographics
Name
NIBRT
Legal name
National Institute of Bioprocessing Research and Training
Website
https://nibrt.ie
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

NIBRT industry classification

Industry
NAICS
Technical and Trade Schools (61151), Technical and Trade Schools (6115), Business Schools and Computer and Management Training (6114), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Industry-Specific Technical & Certification Prep (e.g., Construction, Manufacturing, Energy) (EDAGANAN)
akta.pro secondary industry
Data, Analytics & AI Training (BI, Data Engineering, ML/GenAI) (BPAEANAH)

Keywords

  • Biopharmaceutical training
  • GMP manufacturing training
  • Bioprocessing education
  • ATMP workforce development
  • Pharmaceutical research services

Where NIBRT is headquartered

Location

Headquarters

HQ city
Blackrock
HQ country
Ireland
HQ region
Europe

Offices1 record

Markets served

NIBRT business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Training Services Revenue: NIBRT generates revenue through delivery of customized industry training programs, open enrollment short courses, and online Academy (NOA) licenses to biopharmaceutical companies and individuals. Course fees vary by program type and duration, with group discounts available for organizational licenses.
  2. Academic Programme Fees: Revenue from Masters programmes and certificate courses delivered in partnership with Irish universities (ATU Sligo, DCU, UCD). Programs include Springboard+ co-funded courses where government/EU funding covers 90-100% of costs for eligible participants.
  3. Government and IDA Ireland Funding: Initial facility funding of €57 million from Government of Ireland through IDA Ireland, with additional €21 million for ATMP extension. Ongoing government support for research activities and workforce development initiatives.
  4. Global Partner Licensing: The Global Partners Programme operates on a license model where partner organizations license NIBRT's expertise to provide biopharma training in their regions. Partners include CASTL, BioHub Maryland, K-NIBRT, Institut Pasteur de Dakar, Heartland BioWorks, and others.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSpringboard+ Unemployed Participants - Free
SubscriptionAnnualSpringboard+ Level 6 Programs - Free for All
SubscriptionAnnualSpringboard+ Level 7-9 Employed Participants - 10% Co-payment
One time/ perpetual licensePay-as-you-goNIBRT Global Qualifications (NGQ) Module Fee
Unit PricingPay-as-you-goShort Course Early Bird Discount
SubscriptionAnnualNIBRT Online Academy (NOA) Group Licenses

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

NIBRT product offering

Product offering

Core offering

NIBRT provides training and research services for the biopharmaceutical manufacturing industry through a GMP-simulated facility in Dublin, Ireland. Its core offering is a comprehensive training ecosystem including customised corporate training, open-enrolment short courses, the NIBRT Online Academy (NOA) on-demand e-learning platform, NIBRT Global Qualifications (NGQs) micro-credentials, academic Masters and Certificate programmes, and a Digital Academy curriculum covering AI, data analytics, and Industry 4.0. The institute also conducts industry-aligned research across analytical science, cell and genetic engineering, informatics, and bioprocess engineering, and licenses its curriculum internationally through the Global Partners Programme.

Product overview

NIBRT is a global centre of excellence for biopharmaceutical manufacturing training and research, headquartered in Dublin, Ireland. The core offering is a comprehensive training ecosystem built around a purpose-built, GMP-simulated bioprocessing facility (~8,000 m²) that replicates a modern industrial biopharma plant. This facility supports the primary product — NIBRT Training and Education — which distributes across multiple delivery channels: Customised Industry Training for individual client organisations, Short Open Enrolment Courses on scheduled dates, the NIBRT Online Academy (NOA) on-demand e-learning platform with 55+ modules, Academic Programmes delivered in partnership with ATU Sligo/DCU/UCD, Springboard+ government-funded programmes, and NIBRT Global Qualifications (NGQs) — internationally recognised micro-credentials worth 5 ECTS each. NIBRT's offering is extended by the NIBRT Digital Academy (a structured data/AI/industry 4.0 curriculum developed with Dataworks, GenSpark, and Sartorius), specialised Vaccine Training programmes, and the Global Partners Programme licensing NIBRT's curriculum internationally. Research is delivered through the NIBRT Research division (with Principal Investigators across analytical science, cell/gene engineering, informatics, and bioprocess engineering) and the CONCEPT core facility for early-stage biotherapy development, which hosts the Beacon Optofluidics Platform for single-cell analysis. Major recent expansions include the €21M Advanced Therapies Extension (ATMP facility with seven research labs and two training suites) and the WHO-designated Regional Training Centre for Biomanufacturing in Europe.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Workforce readiness challenges reduced from up to 18 months to shorter timeframes through intensive practical training in GMP-simulated environments
  • +4 more outcomes

Companies that use NIBRT

Customer profile

Named customers12 records

Segments3 records

Ideal customer profiles3 records

NIBRT technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability10 records

Feature6 records

NIBRT partnerships and signals

Strategic signal

Partnerships

25 partnerships are on record, tiered flagship, core and minor.

  • CASTL (Canadian Alliance for Skills and Training in Life Sciences)flagshipStrategic or Co-development Partner · 15 June 2026CASTL is Canada's biomanufacturing training partner and Canada's exclusive provider of NIBRT programmes. The strengthened partnership was recognized in the Joint Statement by Canadian Prime Minister Mark Carney and Irish Taoiseach Micheál Martin. Through a new MOU, the organizations will expand joint programming, share expertise through NIBRT's global network of affiliated training centres, and align world-class biomanufacturing training initiatives.
  • Trinity College DublinflagshipStrategic or Co-development Partner · 11 June 2026TCD partners with NIBRT through joint Principal Investigator appointments (Prof. Sakis Mantalaris, Prof. Nicki Panoskaltsis) and leadership of Rinn Advanced Therapies centre. Prof. Owen Smith from TCD co-leads the centre focusing on personalized advanced cellular immune therapeutics.
  • University of LimerickcoreStrategic or Co-development Partner · 11 June 2026Prof. Damien Thompson at University of Limerick leads Rinn Pharma and Biopharma centre with NIBRT Principal Investigators as co-applicants. The centre focuses on patient-centred medicines and sustainability in drug development.
  • University of GalwayminorStrategic or Co-development Partner · 11 June 2026Prof. Abhay Pandit at University of Galway leads Rinn Medical Devices centre with NIBRT Associate Prof. Radka Fahey as a partner.
  • University College CorkcoreStrategic or Co-development Partner · 11 June 2026UCC partners with NIBRT through Prof. Elena Matsa's joint appointment as Principal Investigator focusing on iPSC Cell Therapy Research and Bioprocess Development.
  • Research IrelandflagshipStrategic or Co-development Partner · 11 June 2026Research Ireland (formerly Science Foundation Ireland) funds the Rinn Research Centres programme with €460 million investment. NIBRT plays central role in three major centres: Rinn Advanced Therapies (€51M), Rinn Pharma and Biopharma (€60M+), and Rinn Medical Devices (€64.5M).
  • BioHub MarylandcoreStrategic or Co-development Partner · 14 May 2026BioHub Maryland partnered with NIBRT to develop specialized biotech workforce training programs supporting Maryland's growing biotech industry. The initiative focuses on advanced training for cell and gene therapies, emphasizing customized education, soft skills development, and regional workforce growth.
  • CytivacoreTechnology or Integration · 13 April 2026Cytiva and NIBRT maintain an ongoing collaboration including the Cytiva Single Use Suite at NIBRT facility and receipt of Cytiva MDPFS PUPSIT System. Cytiva provides advanced bioprocessing equipment for training purposes.
  • K-NIBRT (Korean NIBRT)coreStrategic or Co-development PartnerKorean NIBRT operates as a Global Partner, licensed to deliver NIBRT training programmes in Korea. Partnership supported by Republic of Korea e-Asia, Knowledge Partnership Fund and ADB to combat COVID-19 in Asia and the Pacific.
  • Institut Pasteur de DakarcoreStrategic or Co-development PartnerInstitut Pasteur de Dakar is a Global Partner providing NIBRT training capabilities in Senegal as part of WHO's Regional Training Centre network for Africa.
  • Heartland BioWorkscoreStrategic or Co-development PartnerHeartland BioWorks operates as a Global Partner providing NIBRT training programmes in the US Heartland region to support regional biopharma workforce development.
  • San Jacinto CollegecoreStrategic or Co-development PartnerSan Jacinto College operates as a Global Partner licensed to deliver NIBRT programmes and training curriculum in their region.
  • Biologics Innovation Facility (BIF)coreStrategic or Co-development PartnerBiologics Innovation Facility operates as a Global Partner providing NIBRT-aligned biopharma training and education in their region.
  • UTS (University of Technology Sydney)minorStrategic or Co-development PartnerUniversity of Technology Sydney is a Global Partner exploring biopharma training collaboration in the Australian region.
  • SartoriuscoreTechnology or IntegrationSartorius partners with NIBRT for data analytics training courses including Design of Experiments (DoE) using MODDE software and Multivariate Data Analysis (MVDA) using SIMCA software. Dr Chris McCready, Head of Product Innovation at Sartorius Data Analytics, speaks at NIBRT technical events.
  • DataworkscoreTechnology or IntegrationDataworks partners with NIBRT for digitalization training courses including Excel & Power Query Foundations, Power Platform for Biopharma, and Practical Power BI for Biopharma.
  • GenSparkcoreTechnology or IntegrationGenSpark partners with NIBRT to deliver AI for Biopharma Manufacturing course using the LearnSpark AI learning platform, providing hands-on instructor-led training in NIBRT's GMP-simulated facilities.
  • ATU Sligo (Atlantic Technological University)flagshipStrategic or Co-development PartnerATU Sligo is NIBRT's primary university partner delivering multiple Masters programmes (MSc in ATMP, MSc in BioIndustry 4.0, MSc in Biopharmaceutical Processing, etc.) and Certificate courses. Recognized with Partnership Alliance of the Year Award 2025.
  • DCU (Dublin City University)coreStrategic or Co-development PartnerDCU partners with NIBRT to deliver the MSc in Bioprocess Engineering programme with practical sessions at NIBRT's state-of-the-art facility.
  • UCD (University College Dublin)flagshipStrategic or Co-development PartnerUCD is NIBRT's host institution and key academic partner. NIBRT facility is located on UCD campus. UCD partners include joint appointments for Principal Investigators and delivery of MEngSc Biopharmaceutical Engineering programme.
  • ThermoFisher ScientificcoreStrategic or Co-development PartnerThermoFisher Scientific collaborates with NIBRT on research initiatives. Sponsors the NIBRT Research Conference 2026.
  • DataHowcoreTechnology or IntegrationDataHow partners with NIBRT for technical evenings and training on digital and AI solutions in pharma manufacturing. Dr Alessandro Butté, CEO of DataHow, speaks at NIBRT events on deploying AI in biopharma processes.
  • Boston Consulting GroupminorImplementation/ SI/ Consulting PartnerBoston Consulting Group collaborated with NIBRT on the Biopharma 4.0 project, recognized with Pharma Industry Awards Project of the Year 2020.
  • WHO (World Health Organization)flagshipStrategic or Co-development PartnerWHO designated NIBRT as Regional Training Centre for Biomanufacturing for Europe, one of seven global establishments under WHO's Biomanufacturing Workforce Training Initiative. Initiative aims to address critical workforce shortages and enable sustainable local vaccine and biotherapeutic production capabilities.
  • adMare BioInnovationscoreStrategic or Co-development PartneradMare BioInnovations supports CASTL (NIBRT's Canadian Global Partner) through its adMare Academy, shaping the next generation of life sciences professionals.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

NIBRT competitors and assessment

Company assessment

Direct peers

  • Biologics Innovation Facility (BIF): NIBRT Global Partner delivering NIBRT-aligned biopharma training and education in Australia, operating as one of the eight Global Partners licensing NIBRT's curriculum.
  • CASTL (Canadian Alliance for Skills and Training in Life Sciences): Canada's exclusive provider of NIBRT programmes and biomanufacturing training partner; the June 2026 MOU strengthened joint programming, making it a near-clone of NIBRT's model operating in North America.
  • BTEC (Biomanufacturing Training and Education Center) at NC State University: US-based biomanufacturing training centre at NC State offering hands-on cGMP pilot-scale training comparable to NIBRT's Dublin facility, serving a similar biopharma workforce training mission.
  • BioHub Maryland: NIBRT Global Partner developing specialised biotech workforce training programmes in Maryland with a focus on cell and gene therapies — directly comparable biomanufacturing training mission in the US.
  • BETC (Biomanufacturing Education and Training Center) at Worcester Polytechnic Institute: WPI's BETC delivers industry-aligned biomanufacturing workforce training with pilot-scale facilities, overlapping directly with NIBRT's training-and-research integration model.
  • Institut Pasteur de Dakar: Senegal-based WHO Regional Training Centre for Biomanufacturing for Africa, delivering NIBRT-aligned training as part of WHO's seven-centre global network for biomanufacturing workforce development.
  • San Jacinto College Center for Biotechnology: NIBRT Global Partner delivering licensed NIBRT programmes and training curriculum to biomanufacturing workforce in the Texas Gulf Coast region.
  • K-NIBRT (Korean NIBRT): Korea's licensed NIBRT Global Partner delivering NIBRT-aligned biopharma training programmes in Korea, supported by Republic of Korea e-Asia Knowledge Partnership Fund and ADB.
  • Heartland BioWorks: US Heartland region NIBRT Global Partner providing NIBRT-licensed biopharma training programmes to support regional workforce development.

Emerging players

  • adMare BioInnovations: Canada's life sciences industry developer supporting CASTL's NIBRT-aligned training through adMare Academy; comparable mission of building biopharma workforce capability but with broader industry development scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

NIBRT social profiles

Digital presence

NIBRT compliance and trust

Trust signal

Compliance1 record

NIBRT financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NIBRT leadership team

Management profile

Number of profiles

Profiles10 records

NIBRT funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NIBRT M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NIBRT

What does NIBRT do?

NIBRT provides training and research services for the biopharmaceutical manufacturing industry through a GMP-simulated facility in Dublin, Ireland. Its core offering is a comprehensive training ecosystem including customised corporate training, open-enrolment short courses, the NIBRT Online Academy (NOA) on-demand e-learning platform, NIBRT Global Qualifications (NGQs) micro-credentials, academic Masters and Certificate programmes, and a Digital Academy curriculum covering AI, data analytics, and Industry 4.0. The institute also conducts industry-aligned research across analytical science, cell and genetic engineering, informatics, and bioprocess engineering, and licenses its curriculum internationally through the Global Partners Programme.

Is NIBRT a public or private company?

NIBRT is a private company. It is currently operating.

When was NIBRT founded?

NIBRT was founded in 2011. It employs 101 to 250 people.

Where is NIBRT based?

NIBRT is headquartered in Blackrock, Ireland, in the Europe region.

How does NIBRT make money?

Four revenue lines are on record. Training Services Revenue is the primary driver. The others are academic Programme Fees, government and IDA Ireland Funding and global Partner Licensing.

Who are NIBRT's main competitors?

Direct peers on record are Biologics Innovation Facility (BIF), CASTL (Canadian Alliance for Skills and Training in Life Sciences), BTEC (Biomanufacturing Training and Education Center) at NC State University, BioHub Maryland, BETC (Biomanufacturing Education and Training Center) at Worcester Polytechnic Institute, Institut Pasteur de Dakar, San Jacinto College Center for Biotechnology, K-NIBRT (Korean NIBRT) and Heartland BioWorks. adMare BioInnovations is listed as an emerging player.

Does NIBRT have an API?

No public API is recorded for NIBRT.

What industry is NIBRT in?

Its primary akta.pro industry code is EDAGANAN, Industry-Specific Technical & Certification Prep (e.g., Construction, Manufacturing, Energy), with a secondary code of BPAEANAH, Data, Analytics & AI Training (BI, Data Engineering, ML/GenAI). Its NAICS code is 61151 and its SIC code is 8200.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinanzNachrichten.deEQS-News: SARTORIUS Aktiengesellschaft: Sartorius und NIBRT geben Partnerschaft bekannt: Wegweisendes Trainingszentrum für intensivierte und kontinuierliche Bioprozesse entstehtSartorius and NIBRT announced a partnership to build a training center in Dublin for intensified and continuous bioprocesses, starting in Q4 2026. The center will train over 1,000 professionals annually using Sartorius's Pionic platform, aiming to support the industry's shift to continuous manufacturing.InvestegateEQS-News: Sartorius and NIBRT announce partnership: Pioneering dedicated training center for intensified and continuous bioprocessingSartorius and NIBRT announced a partnership to build a dedicated training center for intensified and continuous bioprocessing in Dublin, Ireland, starting in Q4 2026. The center will train over 1,000 scientists, engineers, and students annually using Sartorius's Pionic technology. It will also support collaborative research and pilot-scale demonstrations.Mirage NewsCanada Boosts Training for Life Sciences SectorCanada announced on August 25, 2026 that it is providing up to $8.7 million to the Canadian Alliance for Skills and Training in Life Sciences under the Sectoral Workforce Solutions Program. The project, Supporting Workforce Capacity in Canada's Biomanufacturing Sector, will train up to 1,800 Canadians, including mid-career, displaced, newcomer and youth workers. CASTL also signed a memorandum of understanding with Ireland's National Institute for Bioprocessing Research and Training.Silicon RepublicIreland’s NIBRT, Canada’s CASTL strengthen partnership for biomanufacturing talentIreland's National Institute for Bioprocessing Research and Training (NIBRT) and Canada's Canadian Alliance for Skills and Training in Life Sciences (CASTL) signed a memorandum of understanding to strengthen their partnership for biomanufacturing workforce development, with the collaboration recognized in a joint statement by Canadian Prime Minister Mark Carney and Irish Taoiseach Micheál Martin during Carney's bilateral visit to Ireland. The MOU enables enhanced joint programming, shared expertise through NIBRT's global network of affiliated training centres, and alignment of world-class biomanufacturing training initiatives. NIBRT was separately selected by the World Health Organization as its Regional Training Centre for Biomanufacturing for Europe, becoming one of seven global establishments under WHO's Biomanufacturing Workforce Training Initiative.NewswireJoint Statement by Prime Minister Mark Carney and Taoiseach Micheál Martin Recognizes CASTL-NIBRT Partnership to Strengthen Biomanufacturing Workforce DevelopmentCASTL and NIBRT signed a Memorandum of Understanding, recognized in a joint statement by Canadian PM Mark Carney and Irish Taoiseach Micheál Martin on June 13, 2026. The partnership aims to strengthen biomanufacturing workforce development through joint programming and shared expertise. CASTL will continue providing industry-aligned training at its three facilities.BioProcess InternationalBioHub Maryland partners with NIBRT to train biotech workersBioHub Maryland has partnered with the National Institute for Bioprocessing Research & Training (NIBRT) to develop specialized biotech workforce training programs aimed at supporting Maryland's growing biotech industry. The initiative focuses on advanced training to meet the needs of expanding biotech modalities, including cell and gene therapies. The partnership emphasizes customized education, soft skills development, and regional workforce growth through events and collaboration.BioProcess InternationalTraining Needs for Advanced-Therapy Regulation and ManufacturingA survey on training needs for advanced-therapy medicinal products (ATMP) and cell and gene therapy (CGT) regulation and manufacturing was conducted by the National Institute for Bioprocessing Research and Training, receiving responses from 11 regulatory experts with over 15 years of industry experience. Survey findings showed strong consensus: 82% agreed a microcredential course for regulators on ATMP manufacturing workflows would be useful, 73% supported a course for manufacturers on regulatory frameworks, and 91% emphasized the importance of quality-risk management and cross-functional understanding. The survey validated two bespoke training courses offered by Atlantic Technological University designed to address identified knowledge gaps between scientific expertise and regulatory compliance requirements in the ATMP sector.DrugdiscoverynewsHow Ireland built an ecosystem for advanced therapy manufacturingIreland has evolved into a global hub for biologics and advanced therapy manufacturing, attracting over €15 billion in foreign direct investment over the past decade and housing nine of the world’s top 10 pharmaceutical companies. The country’s ecosystem centers on the National Institute for Bioprocessing Research and Training (NIBRT), which provides hands-on GMP training in simulated manufacturing environments to address workforce readiness challenges that can take up to 18 months for new employees. Ireland’s deliberate integration of academic research with industry, exemplified by NIBRT’s joint appointments with universities and collaborative research projects, is positioning the country to tackle the increasing complexity of cell and gene therapy manufacturing.BioProcess InternationalIreland’s Global Leadership in BiopharmaceuticalsIreland has transformed from a country with negligible pharmaceutical production in the 1960s to a global biopharmaceutical hub, now hosting over 85 pharmaceutical companies across more than 100 facilities and exporting €72.1 billion in pharmaceutical products annually, accounting for over 5% of global output. Key drivers of this growth include Ireland's 12.5% corporate tax rate, R&D tax credits, a skilled workforce developed through institutions like the National Institute for Bioprocessing Research and Training (NIBRT), a favorable regulatory environment overseen by the Health Products Regulatory Authority (HPRA), and strategic geographic positioning for accessing European and North American markets. NIBRT, established in 2011 with initial government funding of €57 million and later expanded with a €21 million ATMP training facility in 2023, plays a central role in workforce development and bioprocessing research for the sector.Business InsiderHow Ireland is investing in a growing area of biologyIreland is investing in synthetic biology, with the €57 million NIBRT and new facilities planned in 2022. Takeda announced a €36 million plant expansion in Dublin, and MeiraGTx will expand its Shannon facility by end of 2021. The country expects a global manufacturing crunch around 2024.